Orient Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	656.89	587.6	84.5	83.32	76.43	130.92
Short-Term Investments	9.8	39.8	24.8	29.8	20.8	20.8
Cash & Short-Term Investments	666.69	627.4	109.3	113.12	97.23	151.72
Cash Growth	216.65%	474.04%	-3.38%	16.34%	-35.92%	-20.30%
Accounts Receivable	241.21	248.52	278.18	179.31	69.39	63.09
Other Receivables	11.9	16.38	10.36	8.16	12.91	16.82
Receivables	253.11	264.89	288.54	187.47	82.3	79.9
Inventory	324.52	322.39	279.56	233.97	194.18	156.88
Prepaid Expenses	25.1	26.46	44.12	58	39.18	30.91
Other Current Assets	19.64	18	6.91	29.7	10.24	19.89
Total Current Assets	1,289	1,259	728.43	622.25	423.12	439.31
Property, Plant & Equipment	819.26	835.58	891.83	944.96	903.28	769.71
Long-Term Investments	14.16	12.83	13.65	1.88	3.05	1.75
Other Intangible Assets	399.55	414.87	471.83	532.66	11.9	13.75
Long-Term Deferred Tax Assets	351.21	362.29	397.98	451.46	452.04	439.2
Other Long-Term Assets	72.37	53.65	16.87	9.47	54.18	100.1
Total Assets	2,946	2,938	2,521	2,563	1,848	1,764
Accounts Payable	48.43	62.07	36.14	55.57	61.97	19.6
Accrued Expenses	69.61	83.89	69.82	62.04	53.5	59.07
Short-Term Debt	-	-	250	314.5	68.5	161.5
Current Portion of Long-Term Debt	-	-	40	60.71	24.08	23.83
Current Portion of Leases	16.17	16.14	18.44	17.95	14.92	8.22
Current Unearned Revenue	12.07	4.47	64.51	22.01	64.87	78.07
Other Current Liabilities	11.94	20.54	8.35	30.56	63.22	69.17
Total Current Liabilities	158.22	187.1	487.25	563.35	351.06	419.46
Long-Term Debt	-	-	42.1	112.06	178.79	111.8
Long-Term Leases	175.76	179.81	195.95	211.67	221.86	109.67
Pension & Post-Retirement Benefits	6.86	6.81	5.86	5.09	5.94	6.85
Long-Term Deferred Tax Liabilities	1.52	1.15	1.84	-	-	0.13
Total Liabilities	342.35	374.88	733	892.18	757.65	647.9
Common Stock	2,430	2,430	2,230	2,230	1,870	1,870
Additional Paid-In Capital	369.05	369.05	1,130	1,130	932.15	932.15
Retained Earnings	-202.3	-241.01	-1,579	-1,686	-1,709	-1,682
Comprehensive Income & Other	6.14	5.08	6.05	-3.83	-2.89	-4.6
Shareholders' Equity	2,603	2,563	1,788	1,670	1,090	1,116
Total Liabilities & Equity	2,946	2,938	2,521	2,563	1,848	1,764
Total Debt	191.92	195.95	546.49	716.9	508.15	415.01
Net Cash (Debt)	474.77	431.45	-437.19	-603.78	-410.92	-263.29
Net Cash Per Share	2.02	1.87	-1.96	-2.71	-2.20	-1.41
Filing Date Shares Outstanding	243.04	223.04	223.04	223.04	187	187
Total Common Shares Outstanding	243.04	223.04	223.04	223.04	187	187
Working Capital	1,131	1,072	241.18	58.9	72.07	19.86
Book Value Per Share	10.71	11.49	8.01	7.49	5.83	5.97
Tangible Book Value	2,204	2,149	1,316	1,138	1,078	1,102
Tangible Book Value Per Share	9.07	9.63	5.90	5.10	5.76	5.89
Buildings	796.79	796.79	794.16	786.78	744.9	682.91
Machinery	455.78	454.15	439.37	430.96	367.95	361.11